If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms?

[1]  A. Koulov,et al.  Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries. , 2016, Journal of pharmaceutical sciences.

[2]  S. Trudel,et al.  Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site , 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[3]  Wei Wang.  Tolerability of hypertonic injectables. , 2015, International journal of pharmaceutics.

[4]  A. Shaywitz,et al.  Erratum to: Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects , 2015, AAPS PharmSciTech.

[5]  Andrea Allmendinger,et al.  Measuring Tissue Back-Pressure - In Vivo Injection Forces During Subcutaneous Injection , 2014, Pharmaceutical Research.

[6]  J. Dantal.  Intravenous Immunoglobulins: In-Depth Review of Excipients and Acute Kidney Injury Risk , 2013, American Journal of Nephrology.

[7]  B. Suh,et al.  Acid-sensing ion channels (ASICs): therapeutic targets for neurological diseases and their regulation , 2013, BMB reports.

[8]  J. Hussein.  CELL MEMBRANE FATTY ACIDS AND HEALTH , 2013 .

[9]  H. Wang,et al.  Agents that induce pseudo-allergic reaction. , 2011, Drug discoveries & therapeutics.

[10]  Kan Wang,et al.  Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models , 2011, Nanoscale research letters.

[11]  C. Bennett,et al.  Polysorbate 80 hypersensitivity reactions: a renewed call to action , 2010 .

[12]  T. Merdan,et al.  Recent advances in intravenous delivery of poorly water-soluble compounds , 2009, Expert opinion on drug delivery.

[13]  J. Macfie,et al.  ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). , 2009, Clinical nutrition.

[14]  Mohammad O. Tallouzi,et al.  Chemical eye injuries 1: presentation, clinical features, treatment and prognosis. , 2009, Nursing times.

[15]  R. Bucek,et al.  Deep vein thrombosis and systemic inflammatory response: A pilot trial , 2003, Wiener Klinische Wochenschrift.

[16]  T. J. Morgan.  Acid–base balance and disorders , 2009 .

[17]  A. Taddio,et al.  Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials. , 2009, Clinical therapeutics.

[18]  B. Değirmenci,et al.  Hemodynamic changes in the cephalic vein of patients with hemodialysis arteriovenous fistula , 2007, Journal of clinical ultrasound : JCU.

[19]  W. Lambert.  Drug delivery : What the future holds , 2007 .

[20]  J S Patton,et al.  A recombinant human enzyme for enhanced interstitial transport of therapeutics. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J. Deeks,et al.  Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial , 2006, BMJ : British Medical Journal.

[22]  R. Dannenfelser,et al.  In vitro hemolysis: guidance for the pharmaceutical scientist. , 2006, Journal of pharmaceutical sciences.

[23]  Sharon Ms..  Plumer's Principles and Practice of Intravenous Therapy , 2006 .

[24]  T. Laursen,et al.  Pain perception after subcutaneous injections of media containing different buffers. , 2006, Basic & clinical pharmacology & toxicology.

[25]  Janos Szebeni,et al.  Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.

[26]  I. Hessov,et al.  Experimental infusion thrombophlebitis. Importance of the infusion rate , 1976, European journal of intensive care medicine.

[27]  Steven J Shire,et al.  Challenges in the development of high protein concentration formulations. , 2004, Journal of pharmaceutical sciences.

[28]  S. C. Sutton,et al.  Predicting Injection Site Muscle Damage I: Evaluation of Immediate Release Parenteral Formulations in Animal Models , 1996, Pharmaceutical Research.

[29]  E. M. Gibbs,et al.  Predicting Injection Site Muscle Damage III: Evaluation of Intramuscular Formulations in the L6 Cell Model , 1996, Pharmaceutical Research.

[30]  H. Fung,et al.  Use of an in Vitro Model for the Assessment of Muscle Damage from Intramuscular Injections: in Vitro-in Vivo Correlation and Predictability with Mixed Solvent Systems , 1989, Pharmaceutical Research.

[31]  H. Fung,et al.  An In Vitro Model to Evaluate Muscle Damage Following Intramuscular Injections , 1989, Pharmaceutical Research.

[32]  Brian Samas,et al.  An intravenous formulation decision tree for discovery compound formulation development. , 2003, International journal of pharmaceutics.

[33]  G. Volcheck,et al.  The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[34]  U. Seyfert,et al.  In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. , 2002, Biomolecular engineering.

[35]  Marc Stranz,et al.  A Review of pH and Osmolarity. , 2002, International journal of pharmaceutical compounding.

[36]  T. Kuwahara,et al.  Experimental infusion phlebitis: tolerance pH of peripheral vein. , 1999, The Journal of toxicological sciences.

[37]  T. Kuwahara,et al.  Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. , 1998, Nutrition.

[38]  G. Brazeau,et al.  Current perspectives on pain upon injection of drugs. , 1998, Journal of pharmaceutical sciences.

[39]  M. Plebani,et al.  Diagnostic strategies using myoglobin measurement in myocardial infarction. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[40]  S. Yalkowsky,et al.  Lysis of human red blood cells. 3: Effect of contact time on surfactant-induced hemolysis. , 1998, PDA journal of pharmaceutical science and technology.

[41]  T. Kuwahara,et al.  Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition. , 1998, The Journal of toxicological sciences.

[42]  S. Yalkowsky,et al.  Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. , 1997, Journal of pharmaceutical sciences.

[43]  Samuel H. Yalkowsky,et al.  Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis , 1997 .

[44]  L. Arendt-Nielsen,et al.  Quantification of local and referred muscle pain in humans after sequential i.m. injections of hypertonic saline , 1997, Pain.

[45]  S Sweetana,et al.  Solubility principles and practices for parenteral drug dosage form development. , 1996, PDA journal of pharmaceutical science and technology.

[46]  S. Yalkowsky,et al.  Lysis of human red blood cells 1: Effect of contact time on water induced hemolysis. , 1996, PDA journal of pharmaceutical science and technology.

[47]  S. Yalkowsky,et al.  Effect of pH on injection phlebitis. , 1995, Journal of pharmaceutical sciences.

[48]  P. Gupta,et al.  Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model. , 1994, Journal of pharmaceutical science and technology : the official journal of PDA.

[49]  S. Yalkowsky,et al.  Lysis of human red blood cells in the presence of various cosolvents. III. The relationship between hemolytic potential and structure. , 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[50]  K W Reed,et al.  Lysis of human red blood cells in the presence of various cosolvents. II. The effect of differing NaCl concentrations. , 1986, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[51]  P. Williams,et al.  Pain on Injection and Muscle Irritation: A Comparison of Animal Models for Assessing Parenteral Antibiotics , 1986 .

[52]  J. Stoltz.  Hemorheology: pathophysiological significance. , 1985, Acta medica portuguesa.

[53]  K W Reed,et al.  Lysis of human red blood cells in the presence of various cosolvents. , 1985, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[54]  O. Svendsen.  Intramuscular injections and local muscle damage: an experimental study of the effect of injection speed. , 1983, Acta pharmacologica et toxicologica.

[55]  W. P. Cockshott,et al.  Intramuscular or intralipomatous injections? , 1982, The New England journal of medicine.

[56]  Cecie Starr,et al.  Biology: The unity and diversity of life , 1978 .

[57]  L. Worthley.  Hydrogen Ion Metabolism , 1977, Anaesthesia and intensive care.